Roundhill Cannabis ETF (WEED) waives 0.00% fees

WEED ETF to Offer 0.00% Expense Ratio Until July 1, 2025

NEW YORK, July 1, 2024 /PRNewswire/ — Roundhill Investments, an ETF sponsor focused on innovative financial products, announced a fee waiver for its Roundhill Cannabis ETF (Cboe: WEED). The WEED ETF, which provides targeted exposure to major U.S. multi-state carriers, will charge an all-in expense ratio of 0.00% through at least July 1, 2025.

“While regulatory reform in the cannabis industry has been slower than expected, we believe the upcoming Schedule III reclassification can serve as a much-needed catalyst for the industry,” said Dave Mazza, Managing Director of Roundhill Investments. “As we introduce our fee waiver, we encourage investors to consider WEED as a targeted vehicle to express their views on the positive momentum of cannabis in the United States.”

As noted below, Roundhill will waive and limit the total annual operating expenses of the Fund to 0.00% at least until July 1, 2025. This change is effective as of July 1, 2024.

About Roundhill Investments:

Founded in 2018, Roundhill Investments is an SEC-registered investment adviser focused on innovative exchange-traded funds. Roundhill’s suite of ETFs offers unique and differentiated exposures to thematic equities, options income and trading vehicles. Roundhill offers deep ETF knowledge and experience, as the team has collectively launched over 100+ ETFs, including several first-to-market products. To learn more about the firm, please visit roundhillinvestments.com.

Investors should consider the investment objectives, risks, charges and expenses carefully before investing. To obtain a prospectus or summary prospectus containing this and other information about the WEED Cannabis ETF, please call 1-855-561-5728 or visit the website at www.roundhillinvestments.com/etf/WEEDRead the prospectus or simplified prospectus carefully before investing.

The above statements and forecasts are subject to significant business, economic and competitive uncertainties. Accordingly, there can be no assurance that such statements, estimates and projections will come to pass, and no representation is made as to the accuracy or completeness of such statements and forecasts. These statements and forecasts are not indicative of future investment performance. The characteristics and allocations of ETFs are subject to change at any time.

Investing involves risks, including possible loss of capital.

Because the Fund is “non-diversified,” it may invest a higher percentage of its assets in the securities of a single issuer or a smaller number of issuers than if it were a fund diversified. As a result, the Fund may be more exposed to the risks associated with an individual issuer or a smaller number of issuers and developments affecting them than a fund that invests more broadly. This may increase the volatility of the Fund and cause the performance of a relatively small number of issuers to have a greater impact on the performance of the Fund.

Businesses involved in the cannabis industry face intense competition, may have limited access to bank services, may have significant strains on company resources due to litigation, complaints or enforcement actions, and are highly dependent on obtaining the necessary permits and authorizations to engage in medical activities. cannabis research or to cultivate, possess or distribute cannabis. Because the cultivation, possession, and distribution of cannabis may be illegal under United States federal law in certain circumstances, federally regulated banking institutions may be reluctant to make financial services available to producers and cannabis sellers.

Cannabis-related businesses are subject to various laws and regulations that may differ at the state/local and federal levels. Laws and regulations relating to the possession, use (medical or recreational), sale, transportation and cultivation of marijuana vary around the world, and the Fund will only invest in non-U.S. cannabis companies if such companies are legally operating in the relevant jurisdiction. These laws and regulations may (i) significantly affect a cannabis-related business’s ability to obtain financing, (ii) impact the market for marijuana industry sales and services, and (iii) set limits on the use, production, transportation and storage of marijuana.

Additionally, cannabis-related companies are subject to risks associated with the agricultural sector as a whole, including changes or trends that affect commodity prices, labor costs, weather conditions, and laws. and regulations related to environmental protection, health and safety. Cannabis-related companies may also be subject to risks associated with the biotechnology and pharmaceutical industries. These risks include increased government regulation, the use and enforcement of intellectual property rights and patents, technological change and obsolescence, product liability lawsuits and the risk that research and development may not do not necessarily lead to commercially successful products.

As an ETF, the Fund may trade at a premium or discount to NAV. Shares of any ETF are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Because of the costs of buying or selling Shares, including brokerage commissions charged by dealers and bid-ask spreads, frequent trading of Shares may significantly reduce investment results and an investment in Shares may not be advisable for investors who plan to make small investments on a regular basis.

The Fund is a newly established investment company with no operating history. Please see the prospectus for more details on these and other risks.

The fund is distributed by Foreside Fund Services, LLC.
Foreside Fund Services and Roundhill Investments are unaffiliated companies.

SOURCE Roundhill Investments

Source